ALGS Aligos Therapeutics, Inc. - Common stock
$5,40
Fiyat · May 20, 2026
Temel veriler itibarıyla May 7, 2026
52 Haftlık Aralık
$5–$14
3% of range
Analist Derecelendirmesi
BUY
11 analysts
Fiyat Hedefi
$66
+1119% upside
P/E (TTM)
-3.8
ROE
-31.1%
Net Kâr Marjı
-1106.7%
ALGS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$5.40
Piyasa Değeri
$58M
P/E (TTM)
-3.8
EPS (TTM)
$-2.45
Gelir (TTM)
$2M
Temettü Verimi
—
ROE
-31.1%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$5 – $14
ALGS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$2M
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.45
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2020-12-31
→
2024-12-31
Marjlar
-1106.7%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ALGS
Akran Ortalaması
P/E (TTM)
-3.8
—
P/S (TTM) (F/S (TTM))
26.3
21.7
P/B (F/D)
1.1
3.6
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ALGS
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-4024.9%
—
Net Profit Margin (Net Kâr Marjı)
-1106.7%
-994.5%
ROA
-30.5%
-98.6%
ROE
-31.1%
-127.6%
ROIC
-166.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ALGS
Akran Ortalaması
Current Ratio (Cari Oran)
3.9
2.4
Quick Ratio (Cari Oran)
3.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ALGS
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-39.5%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ALGS
Akran Ortalaması
ALGS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
11 analist
- Güçlü Al 3 27,3%
- Al 7 63,6%
- Tut 1 9,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-05-15
Medyan
$48.00
Ortalama
$65.80
← Tüm hedeflerin altında
$5.40
Düşük
$20.00
Yüksek
$175.00
Medyan hedef
$48.00
+788,9%
Ortalama hedef
$65.80
+1118,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.11%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-2.21 | $-2.27 | 0.06% |
| 31 Aralık 2025 | $-1.91 | $-1.89 | -0.02% |
| 30 Eylül 2025 | $-3.04 | $-1.94 | -1.1% |
| 30 Haziran 2025 | $-1.53 | $-2.41 | 0.88% |
| 31 Mart 2025 | $-2.11 | $-2.85 | 0.74% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
| LTRN | — | -1.9 | — | — | — | — |
| BTAI | $36M | -0.3 | -71.7% | -10887.4% | 68.8% | — |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| APLM | — | — | — | — | — | — |
| OTLK | $57M | -0.6 | — | -4416.2% | 193.1% | 4.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $4M | $6M | $0 | $0 | $0 | |
| R&D Expense | $69M | $70M | $73M | $85M | $104M | $80M | |
| SG&A Expense | $21M | $23M | $31M | $26M | $29M | $18M | |
| Operating Expenses | $90M | $93M | $104M | $111M | $133M | $98M | |
| Operating Income | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M | |
| Pretax Income | $-24M | $-131M | $-87M | $-96M | $-128M | $-108M | |
| Income Tax | $314.0K | $331.0K | $795.0K | $106.0K | $143.0K | $161.0K | |
| Net Income | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| EPS (Basic) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| EPS (Diluted) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| Shares (Basic) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| Shares (Diluted) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| EBITDA | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $37M | $136M | $81M | $187M | $220M | |
| Short-term Investments | $60M | $20M | · | $44M | $4M | $23M | |
| Other Current Assets | $5M | $5M | $5M | $8M | $14M | $6M | |
| Current Assets | $83M | $62M | $141M | $134M | $204M | $250M | |
| PP&E (Net) | $2M | $2M | $3M | $5M | $6M | $8M | |
| PP&E (Gross) | $15M | $14M | $14M | $14M | $13M | $12M | |
| Accum. Depreciation | $13M | $12M | $11M | $10M | $7M | $4M | |
| Other Non-current Assets | $715.0K | $627.0K | $625.0K | $634.0K | $866.0K | $377.0K | |
| Total Assets | $89M | $70M | $152M | $147M | $235M | $265M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $3M | $3M | |
| Accrued Liabilities | $14M | $16M | $17M | $16M | $25M | $17M | |
| Current Liabilities | $21M | $22M | $24M | $33M | $39M | $30M | |
| Capital Leases | $2M | $5M | $8M | $9M | $11M | $10M | |
| Other Non-current Liabilities | · | · | · | · | $133.0K | $379.0K | |
| Total Liabilities | $35M | $99M | $59M | $43M | $51M | $45M | |
| Common Stock | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-642M | $-618M | $-487M | $-399M | $-303M | $-175M | |
| AOCI | $468.0K | $451.0K | $545.0K | $401.0K | $452.0K | $-188.0K | |
| Stockholders' Equity | $54M | $-29M | $92M | $104M | $185M | $220M | |
| Liabilities + Equity | $89M | $70M | $152M | $147M | $235M | $265M | |
| Shares Outstanding | 6,178,230 | 3,864,436 | 3,003,855 | 42,922,980 | 42,690,229 | 38,120,606 |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $8M | $13M | $15M | $13M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-83M | $-81M | $-79M | $-79M | $-116M | $-74M | |
| CapEx | · | $130.0K | $19.0K | $943.0K | $892.0K | $2M | |
| Investing Cash Flow | $-38M | $-18M | $45M | $-26M | $3M | $33M | |
| Stock Issued | · | · | $23.0K | · | · | · | |
| Financing Cash Flow | $102M | $355.0K | $88M | $164.0K | $79M | $192M | |
| Taxes Paid | $315.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-81M | $-79M | $-80M | $-117M | $-76M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| Net Margin | -1106.7% | -3633.7% | -1416.2% | · | · | · | |
| Pretax Margin | -1092.4% | -3624.5% | -1403.4% | · | · | · | |
| EBITDA Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| ROA | -30.5% | -118.4% | -58.8% | -50.3% | -51.3% | -52.7% | |
| ROE | -31.1% | -1242.4% | -119.4% | -85.0% | -63.9% | -260.4% | |
| ROIC | -166.5% | 308.5% | -96.6% | -94.0% | -69.5% | -44.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 | 8.3 | |
| Quick Ratio | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 | 8.0 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -39.5% | -41.7% | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | $6M | $0 | $0 | $0 | |
| Net Income TTM | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| Market Cap | $58M | $154M | $1.25B | $1.02B | $12.67B | $25.30B | |
| P/E | -3.8 | -1.9 | -0.5 | -10.6 | · | · | |
| P/S | 26.3 | 42.6 | 201.4 | · | · | · | |
| P/B | 1.1 | -5.3 | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Tangible Book | 1.1 | · | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Cash Flow | -0.7 | -1.9 | -15.8 | -12.9 | -109.5 | -340.7 | |
| P / FCF | · | -1.9 | -15.8 | -12.7 | -108.7 | -331.5 | |
| Earnings Yield | -26.3% | -52.6% | -206.0% | -9.4% | · | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $169.0K | $741.0K | $965.0K | $311.0K | $606.0K | $1M | $1M | $694.0K | $672.0K | $1M | $4M | $140.0K | · | $0 | $0 | |
| R&D Expense | $23M | $17M | $24M | $14M | $15M | $16M | $17M | $21M | $16M | $22M | $16M | $17M | $18M | $19M | $18M | $17M | |
| SG&A Expense | $6M | $5M | $5M | $6M | $5M | $5M | $5M | $6M | $7M | $6M | $6M | $9M | $9M | $7M | $5M | $8M | |
| Operating Expenses | $30M | $22M | $29M | $20M | $20M | $21M | $21M | $27M | $23M | $29M | $22M | $26M | $27M | $26M | $23M | $24M | |
| Operating Income | $-27M | $-22M | $-28M | $-19M | $-19M | $-21M | $-20M | $-26M | $-22M | $-26M | $-19M | $-19M | $-24M | $-23M | $-19M | $-20M | |
| Pretax Income | $-23M | $-20M | $-31M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-18M | $-23M | $-22M | $-19M | $-20M | |
| Income Tax | $317.0K | $30.0K | $56.0K | $185.0K | $43.0K | $27.0K | $91.0K | $189.0K | $24.0K | $-30.0K | $29.0K | $757.0K | $39.0K | $49.0K | $-43.0K | $47.0K | |
| Net Income | $-23M | $-20M | $-32M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-19M | $-23M | $-22M | $-19M | $-20M | |
| EPS (Basic) | $-2.21 | $-3.00 | $-3.04 | $-1.53 | $5.12 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | $-0.47 | |
| EPS (Diluted) | $-2.21 | $4.23 | $-3.04 | $-1.53 | $-2.11 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | $-0.47 | |
| Shares (Basic) | 10,402,967 | -19,244,181 | 10,369,535 | 10,351,120 | 8,408,481 | -12,511,505 | 6,272,291 | 6,257,713 | 6,246,113 | -85,301,920 | 1,739,847 | 43,215,478 | 42,910,065 | -85,243,858 | 42,761,928 | 42,665,598 | |
| Shares (Diluted) | 10,402,967 | -19,545,393 | 10,369,535 | 10,351,120 | 8,709,693 | -12,519,645 | 6,272,291 | 6,265,853 | 6,246,113 | -85,301,920 | 1,739,847 | 43,215,478 | 42,910,065 | -85,243,858 | 42,761,928 | 42,665,598 | |
| EBITDA | $-27M | · | $-28M | $-19M | $-19M | · | $-20M | $-26M | $-22M | · | $-19M | $-19M | $-24M | · | $-19M | $-20M |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $18M | $42M | $19M | $74M | $37M | $35M | $45M | $24M | $136M | $70M | $91M | $79M | $81M | $86M | $71M | |
| Short-term Investments | $25M | $60M | $57M | $104M | $64M | $20M | $40M | $49M | $89M | · | · | $10.0K | $25M | $44M | $56M | $88M | |
| Other Current Assets | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $6M | $8M | $8M | $8M | |
| Current Assets | $60M | $83M | $103M | $128M | $143M | $62M | $80M | $100M | $118M | $141M | $75M | $94M | $109M | $134M | $150M | $168M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $6M | |
| PP&E (Gross) | $15M | $15M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Accum. Depreciation | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | |
| Other Non-current Assets | $759.0K | $715.0K | $713.0K | $640.0K | $632.0K | $627.0K | $635.0K | $631.0K | $625.0K | $625.0K | $623.0K | $624.0K | $632.0K | $634.0K | $653.0K | $616.0K | |
| Total Assets | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | $183M | |
| Accounts Payable | $8M | $4M | $5M | $4M | $4M | $3M | $3M | $7M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $3M | |
| Accrued Liabilities | $12M | $14M | $14M | $12M | $11M | $16M | $14M | $12M | $12M | $17M | $12M | $14M | $15M | $16M | $14M | $13M | |
| Current Liabilities | $23M | $21M | $22M | $20M | $19M | $22M | $21M | $24M | $19M | $24M | $22M | $27M | $28M | $33M | $31M | $32M | |
| Capital Leases | $659.0K | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $133.0K | $133.0K | |
| Total Liabilities | $33M | $35M | $38M | $33M | $34M | $99M | $38M | $42M | $68M | $59M | $31M | $36M | $37M | $43M | $42M | $46M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-665M | $-642M | $-622M | $-591M | $-575M | $-618M | $-536M | $-517M | $-522M | $-487M | $-459M | $-441M | $-422M | $-399M | $-377M | $-359M | |
| AOCI | $438.0K | $468.0K | $455.0K | $420.0K | $447.0K | $451.0K | $577.0K | $494.0K | $476.0K | $545.0K | $497.0K | $497.0K | $499.0K | $401.0K | $159.0K | $50.0K | |
| Stockholders' Equity | $32M | $54M | $72M | $102M | $116M | $-29M | $50M | $67M | $60M | $92M | $55M | $70M | $85M | $104M | $122M | $137M | |
| Liabilities + Equity | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | $183M | |
| Shares Outstanding | 6,188,186 | 6,178,230 | 6,153,507 | 6,151,274 | 6,114,801 | 3,864,436 | 3,324,780 | 79,785,898 | 75,668,521 | 3,003,855 | 43,502,582 | 43,502,582 | 42,940,089 | 42,922,980 | 42,815,593 | 42,808,288 |
Nakit Akışı 6
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $959.0K | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | |
| Operating Cash Flow | $-23M | $-22M | $-24M | $-16M | $-21M | $-18M | $-20M | $-19M | $-23M | $-23M | $-20M | $-14M | $-22M | $-17M | $-17M | $-25M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $91.0K | $3.0K | $334.0K | |
| Investing Cash Flow | $35M | $-2M | $48M | $-39M | $-44M | $20M | $10M | $40M | $-89M | $-7.0K | $-9.0K | $25M | $20M | $12M | $32M | $-10M | |
| Financing Cash Flow | $-62.0K | $123.0K | $-53.0K | $-177.0K | $102M | $97.0K | $-4.0K | $281.0K | $-19.0K | $88M | $-21.0K | $414.0K | $-1.0K | $121.0K | $-19.0K | $83.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | $-22M | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | · | |
| Net Margin | -814.1% | · | -4256.0% | -1643.8% | 13854.7% | · | -1540.7% | 477.0% | -5023.5% | · | -1662.8% | -437.6% | -16396.4% | · | · | · | |
| Pretax Margin | -802.9% | · | -4248.4% | -1624.7% | 13868.5% | · | -1533.4% | 494.8% | -5020.0% | · | -1660.1% | -420.0% | -16368.6% | · | · | · | |
| EBITDA Margin | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | · | |
| ROA | -21.4% | · | -31.8% | -13.0% | 30.9% | · | -22.1% | 4.7% | -27.9% | · | -14.4% | -13.0% | -13.8% | · | -8.7% | -10.1% | |
| ROE | -31.1% | · | -51.7% | -18.8% | 48.9% | · | -36.7% | 7.4% | -48.2% | · | -20.4% | -18.2% | -19.3% | · | -11.0% | -13.0% | |
| ROIC | -85.9% | · | -39.6% | -18.4% | -16.5% | · | -40.4% | -37.9% | -36.9% | · | -34.8% | -28.6% | -28.3% | · | -15.5% | -14.9% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | · | 4.7 | 6.3 | 7.6 | · | 3.8 | 4.2 | 6.3 | · | 3.3 | 3.5 | 3.9 | · | 4.9 | 5.3 | |
| Quick Ratio | 2.4 | · | 4.5 | 6.1 | 7.3 | · | 3.6 | 4.0 | 6.0 | · | 3.1 | 3.3 | 3.7 | · | 4.7 | 5.0 |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | · | $3M | $4M | $3M | · | $4M | $7M | $6M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-27M | · | $-24M | $13M | $-6M | · | $-67M | $-67M | $-95M | · | $-78M | $-80M | $-97M | · | $-107M | $-118M | |
| Market Cap | $46M | · | $60M | $44M | $50M | · | $29M | $698M | $1.85B | · | $812M | $1.06B | $938M | · | $1.18B | $1.29B | |
| P/E | -0.8 | · | -1.0 | -1.2 | -0.8 | · | -0.5 | -0.6 | -1.4 | · | -1.6 | -13.0 | -9.6 | · | -10.9 | · | |
| P/S | 9.5 | · | 18.5 | 12.4 | 15.2 | · | 7.0 | 97.9 | 298.4 | · | 147.2 | 238.2 | · | · | · | · | |
| P/B | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | 9.5 | |
| P / Tangible Book | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | 9.5 | |
| P / Cash Flow | -2.0 | · | · | · | -2.4 | · | · | · | -81.5 | · | · | · | -41.9 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | -41.9 | · | · | · | |
| Earnings Yield | -119.6% | · | -99.5% | -81.8% | -120.6% | · | -210.3% | -177.9% | -69.0% | · | -63.0% | -7.7% | -10.4% | · | -9.2% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $2M | $4M | $6M | $0 | $0 |
| Faaliyet Kâr Marjı % | -4024.9% | -2469.0% | -1423.5% | — | — |
| Net Gelir | $-24M | $-131M | $-88M | $-96M | $-128M |
| Seyreltilmiş Hisse Başı Kâr | $-2.45 | $-20.94 | $-34.20 | $-2.25 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 |
| Cari Oran | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-81M | $-79M | $-80M | $-117M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.